Trademarkia Logo

Australia

AU$
NEARVUE
Cancelled: Cancelled at the request of IB

Last updated on 18 Sept 2023

Owner Info

Visus Therapeutics Inc.

2 Nickerson Street,

Suite 101, UNITED STATES OF AMERICA

Serial Number

2221793 filed on 7 Sept 2021

Correspondent

Matthew E. Moersfelder Davis Wright Tremaine LLP

920 Fifth Avenue, Suite 3300,

Seattle WA 98104,

UNITED STATES OF AMERICA

NEARVUE

Classification Information


Class [005]
Ophthalmic drugs.

Mark Details


Serial Number

2221793

Registered On

7 Sept 2021

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

12 Mar 2021

Mark Type

US

Legal History


Show more

Status DateAction Taken
18th Sept 2023Status change to Voided
12th Jan 2022International Registration in Australia Protected correspondence sent
11th Jan 2022IP Right Registration Published
11th Jan 2022Status change to Registered/Protected
16th Dec 2021Amendment to Amend Owner Requested
3rd Nov 2021Application Accepted correspondence sent
28th Oct 2021Application Accepted correspondence sent
27th Oct 2021IP Right has been Examined
27th Oct 2021IP Right Acceptance Published
27th Oct 2021Status change to Accepted